WST - West Pharmaceutical reports mixed Q4 results; initiates FY24 outlook
2024-02-15 06:09:26 ET
More on West Pharmaceutical
- West Pharmaceutical Services: A Solid Buy For Long-Term Investors
- West Pharmaceutical: Great Business, Not So Great Valuation
- Tudor Investment exits Airbnb, Adobe; boosts Nvidia, Splunk
- West Pharmaceutical Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on West Pharmaceutical